NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 76329-6300-05 — Lidocaine 4% topical solutionAI (974 hospitals, 52,706–57,602 samples)
• NDC 00409-9045-01 — Bupivacaine with epinephrine numbing injectionAI (395 hospitals, 56,239–57,598 samples)
• NDC 00409-6648-16 — Dextrose 50% injectionAI (380 hospitals, 56,123–57,590 samples)
• NDC 42023-0216-01 — Ephedrine sulfate injection, 50 mg/mL vialAI (337 hospitals, 56,341–57,583 samples)
• NDC 42023-0216-25 — Ephedrine sulfate injection, 50 mg/mL vialAI (494 hospitals, 55,987–57,544 samples)
• NDC 00093-6816-19 — Budesonide inhalation suspension 0.5 mg per 2 mLAI (384 hospitals, 56,355–57,516 samples)
• NDC 00409-6637-24 — Intravenous sodium bicarbonate 8.4% solutionAI (381 hospitals, 54,834–57,516 samples)
• NDC 25021-0662-05 — Rocuronium bromide injection, 50 mg per 5 mLAI (289 hospitals, 55,905–57,507 samples)
• NDC 00409-4092-01 — Cupric chloride intravenous solutionAI (545 hospitals, 55,844–57,500 samples)
• NDC 69097-0173-53 — Ipratropium and albuterol nebulizer solutionAI (295 hospitals, 56,112–57,480 samples)
• NDC 00409-9094-61 — Fentanyl citrate injection, preservative-free, 2,500 mcg in 50 mLAI (599 hospitals, 39,397–57,469 samples)
• NDC 76204-0600-30 — Ipratropium-albuterol nebulizer solutionAI (380 hospitals, 56,167–57,454 samples)
• NDC 72485-0105-01 — Sodium nitroprusside injection (IV solution)AI (520 hospitals, 56,374–57,427 samples)
• NDC 60687-0524-83 — Budesonide 0.5 mg/2 mL inhalation suspensionAI (578 hospitals, 56,010–57,414 samples)
• NDC 76204-0600-60 — Ipratropium-albuterol nebulizer solutionAI (268 hospitals, 56,118–57,414 samples)
• NDC 63323-0468-01 — Bupivacaine with epinephrine numbing injectionAI (305 hospitals, 56,130–57,408 samples)
• NDC 43598-0725-25 — Ephedrine sulfate injection, a blood pressure medicineAI (335 hospitals, 56,111–57,407 samples)
• NDC 76204-0200-30 — Albuterol sulfate 2.5 mg nebulizer solutionAI (436 hospitals, 55,763–57,401 samples)
• NDC 47335-0932-40 — Vecuronium bromide 20 mg injection vialAI (178 hospitals, 55,595–57,395 samples)
• NDC 00409-9558-05 — Rocuronium bromide injection, 50 mg per 5 mLAI (439 hospitals, 55,923–57,381 samples)
• NDC 69097-0173-64 — Ipratropium and albuterol nebulizer solutionAI (161 hospitals, 56,102–57,380 samples)
• NDC 72266-0123-01 — Ondansetron injection 4 mg per 2 mLAI (197 hospitals, 53,954–57,356 samples)
• NDC 67457-0228-10 — Rocuronium bromide injection, 100 mg per 10 mLAI (285 hospitals, 55,995–57,336 samples)
• NDC 00487-9003-30 — Sodium chloride 3% nebulizer solutionAI (431 hospitals, 56,313–57,330 samples)
• NDC 42023-0123-06 — Dantrolene 20 mg vial, reconstituted solutionAI (648 hospitals, 56,002–57,325 samples)
• NDC 70069-0161-01 — Cisatracurium injection, 2 mg/mLAI (254 hospitals, 56,065–57,325 samples)
• NDC 00781-3755-95 — Norepinephrine intravenous solution, 1 mg/mLAI (247 hospitals, 56,179–57,295 samples)
• NDC 00409-1632-21 — Vecuronium bromide 10 mg injectionAI (218 hospitals, 55,473–57,255 samples)
• NDC 00143-9507-01 — Etomidate injection (intravenous anesthetic)AI (387 hospitals, 56,039–57,254 samples)
• NDC 00409-1749-70 — Bupivacaine with epinephrine local anesthetic injectionAI (298 hospitals, 56,039–57,254 samples)
• NDC 47335-0931-44 — Vecuronium bromide 10 mg injectionAI (437 hospitals, 56,094–57,246 samples)
• NDC 51754-0203-02 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (244 hospitals, 56,038–57,244 samples)
• NDC 00143-9250-10 — Rocuronium injection, 10 mg/mLAI (274 hospitals, 55,869–57,228 samples)
• NDC 00186-1989-04 — Budesonide 0.5 mg nebulizer solutionAI (397 hospitals, 56,136–57,225 samples)
• NDC 69097-0173-48 — Ipratropium and albuterol nebulizer solutionAI (182 hospitals, 56,063–57,197 samples)
• NDC 36000-0162-10 — Norepinephrine 1 mg/mL intravenous solutionAI (348 hospitals, 56,139–57,183 samples)
• NDC 00409-3382-21 — Sufentanil citrate IV solutionAI (355 hospitals, 55,877–57,164 samples)
• NDC 43598-0078-58 — Enalaprilat injection (intravenous blood pressure medicine)AI (302 hospitals, 55,880–57,158 samples)
• NDC 00409-6695-11 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (207 hospitals, 56,007–57,123 samples)
• NDC 23155-0548-42 — Ondansetron 4 mg/2 mL injectionAI (256 hospitals, 55,611–57,114 samples)
• NDC 70436-0028-80 — Sodium nitroprusside 25 mg/mL IV solutionAI (313 hospitals, 55,826–57,104 samples)
• NDC 59365-6065-01 — Astringyn 259 mg per gram external solutionAI (299 hospitals, 55,861–57,103 samples)
• NDC 36000-0148-01 — Flumazenil IV injection (benzodiazepine reversal agent)AI (434 hospitals, 55,844–57,059 samples)
• NDC 70069-0271-05 — Verapamil hydrochloride injection, 2.5 mg/mLAI (231 hospitals, 55,793–57,044 samples)
• NDC 55150-0235-10 — Vecuronium 10 mg vialAI (629 hospitals, 55,864–57,025 samples)
• NDC 70069-0271-25 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (253 hospitals, 55,817–57,023 samples)
• NDC 55150-0304-25 — Dexamethasone sodium phosphate 10 mg/mL injectionAI (526 hospitals, 47,251–56,980 samples)
• NDC 71288-0712-06 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (285 hospitals, 55,818–56,952 samples)
• NDC 55150-0166-13 — Sildenafil 10 mg/12.5 mL intravenous solutionAI (301 hospitals, 55,492–56,950 samples)
• NDC 39822-4200-01 — Rocuronium bromide injection, 50 mg per 5 mLAI (327 hospitals, 55,647–56,943 samples)